Cargando…
AstraZeneca COVID-19 vaccine recommended in ≥50s in Australia
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103116/ http://dx.doi.org/10.1007/s40278-021-95332-1 |
Ejemplares similares
-
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021) -
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
Bleeding and clotting with AstraZeneca's COVID-19 vaccine
Publicado: (2021) -
AstraZeneca COVID-19 vaccine not recommended in adults under 55 in Canada
Publicado: (2021) -
No increased risk of anaphylaxis with AstraZeneca COVID-19 vaccine
Publicado: (2021)